[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365464-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365464-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-chain-fatty-acyl-coa-synthetase-4-expression-in-pancreatic-cancer-a-marker-for-malignant-lesions-and-prognostic-indicator-for-recurrence","Long-chain fatty acyl CoA synthetase 4 expression in pancreatic cancer - a marker for malignant lesions and prognostic indicator for recurrence","","Long-chain fatty acyl CoA synthetase 4 (ACSL4) supports lipid metabolism by catalyzing formation of 12–20 carbon chain fatty acids and is reported to be upregulated in cancers. This study evaluates ACSL4 expression in pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm (IPMN) and determines its diagnostic and clinical relevance. Immunohistochemistry in 165 patients shows higher ACSL4 in invasive lesions, while low expression correlates with lymphovascular invasion, recurrence, and worse disease-free survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-chain-fatty-acyl-coa-synthetase-4-expression-in-pancreatic-cancer-a-marker-for-malignant-lesions-and-prognostic-indicator-for-recurrence/365464/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-chain-fatty-acyl-coa-synthetase-4-expression-in-pancreatic-cancer-a-marker-for-malignant-lesions-and-prognostic-indicator-for-recurrence/365464.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding ACSL4 in pancreatic cancer?","Question",{"text":63,"@type":64},"To investigate ACSL4 expression in PDAC and IPMN and evaluate its diagnostic value and clinical implications for recurrence.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was ACSL4 expression measured and compared between lesion types?",{"text":68,"@type":64},"ACSL4 expression was assessed by immunohistochemistry in 165 patients, and differences between malignant and benign lesions were tested using the Pearson χ2 test.",{"name":70,"@type":61,"acceptedAnswer":71},"What does low ACSL4 expression indicate clinically?",{"text":72,"@type":64},"Low ACSL4 expression in invasive cancers is associated with higher lymphovascular invasion and recurrence and with shorter disease-free survival, and it remains an independent prognostic factor in multivariable Cox regression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365464,1790180653,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Uchihara etal. Diagnostic Pathology (2025) 20:59  \n[https://doi.org/10.1186/s13000-025-01659-6](https://doi.org/10.1186/s13000-025-01659-6)  \nDiagnostic Pathology  \nRESEARCH Open Access  \nLong-chain fatty acyl CoA synthetase 4  expression in pancreatic cancer: a marker for malignant lesions and prognostic indicator for recurrence  \nDaiki Uchihara 1,2*, Shohei Shimajiri 1, Yoshikazu Harada 1, Keiichiro Kumamoto 1,2, Shinji Oe2, Koichiro Miyagawa2, Koichi Nakamura 1,2, Eisuke Katafuchi 1, Fariza Nuratdinova 1, Yuichi Honma2, Michihiko Shibata2, Masaru Harada2 and Toshiyuki Nakayama 1  \nAbstract  \nBackground Long-chain fatty acyl CoA synthetase 4 (ACSL4) is crucial for lipid metabolism, primarily catalyzing the formation of 12–20 carbon chain fatty acids. ACSL4 is upregulated in various cancers and linked to aggressive behavior and poor survival. A bioinformatics study showing ACSL4 upregulation in pancreatic cancer. However, utility for actual pathological diagnosis and clinical significance in pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm (IPMN) are unexplored. This study aimed to investigate ACSL4 expression in PDAC and IPMN, and evaluate its clinical implications.  \nMethods We examined ACSL4 expression using immunohistochemistry in 165 patients with PDAC and IPMN. Differences in ACSL4 expression between malignant and benign lesions were evaluated using the Pearson χ2 test. The association between ACSL4 expression, pathological parameters, and survival was assessed through Kaplan-Meier and Cox regression analyses in 96 patients with invasive cancer.  \nResults Compared to normal pancreatic ducts, low-grade pancreatic intraepithelial neoplasm, and intraductal papillary mucinous adenoma (IPMA) (3 . 3%, 3 .4%, and 2. 7%, respectively), ACSL4 expression was significantly higher in invasive PDAC, noninvasive intraductal papillary mucinous carcinoma (IPMC), and invasive IPMC (77%, 86. 7%, and 93. 9%, respectively) . In invasive cancers, low ACSL4 expression was associated with a higher frequency of lymphovascular invasion and recurrence and shorter disease-free survival (P = 0 . 006) . Additionally, low ACSL4 expression was an independent prognostic factor for shorter disease-free survival in multivariable Cox regression analysis (HR = 2 .409, 95% CI: 1.121–5. 180, P = 0 . 024) .  \nConclusion ACSL4 expression helps differentiate cancerous from precancerous lesions in pancreatic cancer, but low expression is linked to a higher frequency of lymphovascular invasion and shorter disease-free survival in invasive  \n*Correspondence: Daiki Uchihara  \nuchihara-daiki [1127@med.uoeh-u.ac.jp](1127@med.uoeh-u.ac.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nUchihara et al. Diagnostic Pathology (2025) 20:59 Page 2 of 12  \ncases. Due to the limited sample size and broad confidence intervals, the findings ofthis study","cbCaiqTNRYDu5uMc","https://ap.wps.com/l/cbCaiqTNRYDu5uMc","pdf",2435316,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods\n## Immunohistochemistry cohort\n## Statistical analyses\n# Results\n## Expression differences\n## Associations with pathology and survival\n# Conclusion","[{\"question\":\"What is the study’s main goal regarding ACSL4 in pancreatic cancer?\",\"answer\":\"To investigate ACSL4 expression in PDAC and IPMN and evaluate its diagnostic value and clinical implications for recurrence.\"},{\"question\":\"How was ACSL4 expression measured and compared between lesion types?\",\"answer\":\"ACSL4 expression was assessed by immunohistochemistry in 165 patients, and differences between malignant and benign lesions were tested using the Pearson χ2 test.\"},{\"question\":\"What does low ACSL4 expression indicate clinically?\",\"answer\":\"Low ACSL4 expression in invasive cancers is associated with higher lymphovascular invasion and recurrence and with shorter disease-free survival, and it remains an independent prognostic factor in multivariable Cox regression.\"}]","Long-chain fatty acyl CoA synthetase 4 expression in pancreatic cancer - a marker for malignant lesions and prognostic indicator for recurrence | PDF",1790160999,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb969a5476c8c7afbe90b97fa69f482b.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f4fdc09dc731194c4ef43bfeee9a01e.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2563cdbd27789744104357cea87ff0c1.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07d8ca9b591872e063cb4505cfc1913f.webp",980,1306]